Determining factors for Cannabis use among Moroccans Schizophrenic Patients: A cross sectional study

Autor: Bouri Sara, Zemmama Hanane, El Ayoubi Idrissi Khadija, Berraho Mohamed Amine, Abdellaoui Abdelfattah, Badiaa Lyoussi, Rammouz Ismail, Achour Sanae

Publikováno v: Avicenna Journal of Phytomedicine, Vol 10, Iss 1, Pp 89-100 (2019)

Objective: Cannabis use is considered a major clinical problem associated with a poorer outcome in patients with schizophrenia. The objective of the present study was to assess the prevalence of cannabis us among patients with schizophrenia. The asse

Externí odkaz: https://doaj.org/article/f7c6e0265f974714a1aae9391c4be954

Reliability of self-report of cannabis use among patients with schizophrenia

Autor: Rammouz, Ismail, Bouri, Sara, Merzouki, Mohamed, Berraho, Mohamed Amine, Aalouane, Rachid, Boujraf, Saïd

Publikováno v: In Psychiatry Research May 2022 311

Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study.

Autor: Rammouz I; Faculty of Medicine, Health Sciences Research Laboratory, Ibn Zohr University, Agadir, Morocco., Merzouki M; Faculté de Sciences et Techniques, Moulay Sliman University, Beni Mellal, Morocco., Bouri S; Faculty of Medicine, Clinical Neurosciences Laboratory, Sidi Mohamed Ben Abdellah University, Fez, Morocco., Rachid A; Faculty of Medicine, Clinical Neurosciences Laboratory, Sidi Mohamed Ben Abdellah University, Fez, Morocco., Bout A; Faculty of Medicine, Clinical Neurosciences Laboratory, Sidi Mohamed Ben Abdellah University, Fez, Morocco., Boujraf S; Faculty of Medicine, Clinical Neurosciences Laboratory, Sidi Mohamed Ben Abdellah University, Fez, Morocco.

Publikováno v: Central nervous system agents in medicinal chemistry [Cent Nerv Syst Agents Med Chem] 2022; Vol. 22 (3), pp. 188-197.